INMB Inmune Bio, Inc.: institutional ownership and insider trading
82 funds reported holding $8.98M of Inmune Bio, Inc. in their latest 13F filings; in Q2 2026 funds net sold $1.62M, with 22 new positions and 21 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
INMB revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$1.27M, EPS -0.05
- Quarter ended Mar 31, 2026: revenue n/a, net income −$5.41M, EPS -0.20
- Quarter ended Dec 31, 2025: revenue n/a, net income −$5.33M, EPS -0.14
- Quarter ended Sep 30, 2025: revenue n/a, net income −$6.47M, EPS -0.24
Famous investors holding INMB
- Izzy Englander (Millennium Management): $260K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $201K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $48.4K, 0.0% of the portfolio
Largest institutional holders of INMB
- VANGUARD GROUP INC — $1.49M
- VANGUARD CAPITAL MANAGEMENT LLC — $1.15M
- AQR CAPITAL MANAGEMENT LLC — $1.08M
- BlackRock, Inc. (BLK) — $508K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $392K
- RAYMOND JAMES FINANCIAL INC (RJF, RJF-PB) — $347K
- GEODE CAPITAL MANAGEMENT, LLC — $310K
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $302K
- MILLENNIUM MANAGEMENT LLC — $260K
- JANE STREET GROUP, LLC — $219K
5%+ owners
- Highbridge Capital Management, LLC: 5.2% (Schedule 13G/A, filed Aug 14, 2025)
Who owns the most INMB stock?
The largest institutional holders of Inmune Bio, Inc. in the latest 13F filings are VANGUARD GROUP INC ($1.49M), VANGUARD CAPITAL MANAGEMENT LLC ($1.15M), AQR CAPITAL MANAGEMENT LLC ($1.08M).
Are insiders buying or selling INMB?
No open-market insider buys or sells of Inmune Bio, Inc. were reported in the last 12 months.
Which famous investors own INMB?
Izzy Englander, Ken Griffin, Renaissance Technologies.